UQCC4
gene geneOn this page
Also known as gs103CCSMST1URLC5
Summary
UQCC4 (ubiquinol-cytochrome c reductase complex assembly factor 4, HGNC:27558) is a protein-coding gene on chromosome 16p13.3, encoding Ubiquinol-cytochrome c reductase complex assembly factor 4 (Q4G0I0). Required for the assembly and stability of the mitochondrial ubiquinol-cytochrome c reductase complex (complex III (CIII) or cytochrome b-c1 complex), a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain (ETC) which drives oxidative pho….
Predicted to be involved in mitochondrial respiratory chain complex III assembly. Located in mitochondrion.
Source: NCBI Gene 283951 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001272051
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27558 |
| Approved symbol | UQCC4 |
| Name | ubiquinol-cytochrome c reductase complex assembly factor 4 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | gs103, CCSMST1, URLC5 |
| Ensembl gene | ENSG00000174109 |
| Ensembl biotype | protein_coding |
| OMIM | 620578 |
| Entrez | 283951 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 retained_intron
ENST00000442039, ENST00000563974
RefSeq mRNA: 1 — MANE Select: NM_001272051
NM_001272051
CCDS: CCDS61789
Canonical transcript exons
ENST00000442039 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001769495 | 1419752 | 1420612 |
| ENSE00001801629 | 1420692 | 1420747 |
Expression profiles
Bgee: expression breadth ubiquitous, 238 present calls, max score 89.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.9750 / max 83.3943, expressed in 1804 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 155844 | 12.9750 | 1804 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| upper arm skin | UBERON:0004263 | 89.35 | silver quality |
| tibialis anterior | UBERON:0001385 | 88.89 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.69 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.44 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.76 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.76 | gold quality |
| left adrenal gland | UBERON:0001234 | 86.60 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 86.47 | gold quality |
| deltoid | UBERON:0001476 | 86.28 | silver quality |
| gastrocnemius | UBERON:0001388 | 86.23 | gold quality |
| adrenal cortex | UBERON:0001235 | 86.21 | gold quality |
| prefrontal cortex | UBERON:0000451 | 86.06 | gold quality |
| kidney epithelium | UBERON:0004819 | 86.03 | gold quality |
| ileal mucosa | UBERON:0000331 | 85.87 | gold quality |
| muscle of leg | UBERON:0001383 | 85.63 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 85.43 | silver quality |
| apex of heart | UBERON:0002098 | 85.28 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.19 | gold quality |
| adrenal gland | UBERON:0002369 | 84.88 | gold quality |
| heart left ventricle | UBERON:0002084 | 84.82 | gold quality |
| cortical plate | UBERON:0005343 | 84.78 | gold quality |
| cardiac ventricle | UBERON:0002082 | 84.68 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 84.63 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 84.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 84.12 | gold quality |
| frontal cortex | UBERON:0001870 | 83.94 | gold quality |
| cerebellar vermis | UBERON:0004720 | 83.92 | gold quality |
| skin of leg | UBERON:0001511 | 83.87 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 83.82 | gold quality |
| quadriceps femoris | UBERON:0001377 | 83.81 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.65 |
| E-MTAB-7052 | no | 89.71 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | uqcc4 | ENSDARG00000100025 |
| mus_musculus | Uqcc4 | ENSMUSG00000067722 |
| rattus_norvegicus | Uqcc4 | ENSRNOG00000029415 |
Protein
Protein identifiers
Ubiquinol-cytochrome c reductase complex assembly factor 4 — Q4G0I0 (reviewed: Q4G0I0)
Alternative names: Protein CCSMST1
All UniProt accessions (2): Q4G0I0, A0A0A8K8N9
UniProt curated annotations — full annotation on UniProt →
Function. Required for the assembly and stability of the mitochondrial ubiquinol-cytochrome c reductase complex (complex III (CIII) or cytochrome b-c1 complex), a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain (ETC) which drives oxidative phosphorylation.
Subunit / interactions. Forms a complex, named COMB/coordinator of mitochondrial CYTB biogenesis, composed of UQCC1, UQCC2, UQCC4, UQCC5 and UQCC6; stabilizes nascent cytochrome b/MT-CYB and promotes its membrane insertion. Forms a complex, named COMA, composed of UQCC1, UQCC2 and UQCC4; activates MT-CYB translation. Forms a complex, named COMC, composed of UQCC1, UQCC2; UQCC3 and UQCC4; mediates MT-CYB hemylation and association with the first nuclear-encoded complex III subunit UQCRQ. Complexes COMA and COMB are bound to the mitochondrion inner membrane by UQCC4.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the UQCC4 family.
RefSeq proteins (1): NP_001258980* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR023248 | UQCC4_vert | Family |
| IPR029160 | UQCC4 | Family |
Pfam: PF15013
UniProt features (7 total): topological domain 2, region of interest 2, signal peptide 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4G0I0-F1 | 63.40 | 0.07 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 60 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, GOBP_CYTOCHROME_COMPLEX_ASSEMBLY, GOCC_MITOCHONDRIAL_ENVELOPE, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, ACEVEDO_LIVER_CANCER_UP, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, GOCC_ORGANELLE_INNER_MEMBRANE, NIKOLSKY_BREAST_CANCER_16P13_AMPLICON, GOCC_ORGANELLE_ENVELOPE, EIF4E_UP, BCL6B_TARGET_GENES
GO Biological Process (1): mitochondrial respiratory chain complex III assembly (GO:0034551)
GO Molecular Function (0):
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 1 |
| respiratory chain complex III assembly | 1 |
| mitochondrial respiratory chain complex assembly | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
282 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| UQCC4 | C15orf61 | A6NNL5 | 511 |
| UQCC4 | GKN2 | Q86XP6 | 509 |
| UQCC4 | GKN1 | Q9NS71 | 485 |
| UQCC4 | MAGEF1 | Q9HAY2 | 395 |
| UQCC4 | NDUFAF8 | A1L188 | 392 |
| UQCC4 | DMAC1 | Q96GE9 | 367 |
| UQCC4 | RCN2 | Q14257 | 366 |
| UQCC4 | CEBPZOS | A8MTT3 | 352 |
| UQCC4 | QTRT1 | Q9BXR0 | 348 |
| UQCC4 | NTMT1 | Q9BV86 | 324 |
| UQCC4 | HMBS | P08396 | 319 |
| UQCC4 | FRYL | O94915 | 301 |
| UQCC4 | ACTBL2 | Q562R1 | 298 |
| UQCC4 | BOLA3 | Q53S33 | 296 |
| UQCC4 | FLAD1 | Q8NFF5 | 294 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COX20 | ECM1 | psi-mi:“MI:0914”(association) | 0.350 |
| PLOD3 | psi-mi:“MI:0914”(association) | 0.350 | |
| CHODL | RAD51C | psi-mi:“MI:0914”(association) | 0.350 |
| UQCC2 | UQCC4 | psi-mi:“MI:0914”(association) | 0.350 |
| COX20 | UQCC4 | psi-mi:“MI:0914”(association) | 0.350 |
| CLMN | UQCC4 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): C16orf91 (Affinity Capture-MS), C16orf91 (Affinity Capture-MS), C16orf91 (Affinity Capture-MS), C16orf91 (Affinity Capture-MS), C16orf91 (Affinity Capture-MS), C16orf91 (Affinity Capture-MS), C16orf91 (Affinity Capture-RNA)
ESM2 similar proteins: A1A4P4, A1CH36, A2ALW5, A5AAL8, B0BN56, O42911, O70279, P0C2B7, P58468, P83565, Q0CLE8, Q1ECT8, Q290P4, Q2GVC2, Q3SZ86, Q4G0I0, Q4V7Q1, Q5B4U6, Q5BJW9, Q5RFR4, Q5XJW2, Q61733, Q6RUT7, Q753F1, Q7SDU5, Q7SHR9, Q80ZS3, Q86TS9, Q8BGX2, Q8BK72, Q8CHP5, Q8SPE7, Q8TAE8, Q8VD26, Q8WUQ7, Q96AN5, Q96DF8, Q9BRP8, Q9BSF4, Q9BYN8
Diamond homologs: A8WGU8, Q1ECT8, Q4G0I0, Q5RFR4, Q6RUT7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
186 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:1420728:G:GA | donor_gain | 0.9900 |
| 16:1420685:AGCT:A | donor_loss | 0.9800 |
| 16:1420686:GCTC:G | donor_loss | 0.9800 |
| 16:1420687:CT:C | donor_loss | 0.9800 |
| 16:1420688:TCAC:T | donor_loss | 0.9800 |
| 16:1420689:CACC:C | donor_loss | 0.9800 |
| 16:1420690:A:AG | donor_loss | 0.9800 |
| 16:1420690:AC:A | donor_gain | 0.9800 |
| 16:1420691:CC:C | donor_gain | 0.9800 |
| 16:1420691:CCCGG:C | donor_gain | 0.9800 |
| 16:1420746:ACG:A | donor_gain | 0.9800 |
| 16:1420747:CGC:C | donor_gain | 0.9800 |
| 16:1420690:A:AC | donor_gain | 0.9700 |
| 16:1420691:C:CC | donor_gain | 0.9700 |
| 16:1420737:C:CA | donor_gain | 0.9600 |
| 16:1420608:CGGCC:C | acceptor_gain | 0.9500 |
| 16:1420745:G:T | donor_gain | 0.9500 |
| 16:1420613:C:CC | acceptor_gain | 0.9400 |
| 16:1420736:T:TA | donor_gain | 0.9200 |
| 16:1420610:GCCC:G | acceptor_loss | 0.9100 |
| 16:1420612:CCT:C | acceptor_loss | 0.9100 |
| 16:1420614:T:A | acceptor_loss | 0.9100 |
| 16:1420611:CC:C | acceptor_gain | 0.8800 |
| 16:1420612:CC:C | acceptor_gain | 0.8800 |
| 16:1420671:CCGAG:C | donor_gain | 0.8800 |
| 16:1420610:GCC:G | acceptor_gain | 0.8700 |
| 16:1420611:CCC:C | acceptor_gain | 0.8700 |
| 16:1420609:GGCC:G | acceptor_gain | 0.8500 |
| 16:1420726:C:CT | donor_gain | 0.8500 |
| 16:1420727:T:TT | donor_gain | 0.8500 |
AlphaMissense
849 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:1420489:A:C | F52L | 0.986 |
| 16:1420489:A:T | F52L | 0.986 |
| 16:1420491:A:G | F52L | 0.986 |
| 16:1420396:G:C | S83R | 0.978 |
| 16:1420396:G:T | S83R | 0.978 |
| 16:1420398:T:G | S83R | 0.978 |
| 16:1420490:A:C | F52C | 0.930 |
| 16:1420395:A:G | C84R | 0.927 |
| 16:1420480:G:C | S55R | 0.927 |
| 16:1420480:G:T | S55R | 0.927 |
| 16:1420482:T:G | S55R | 0.927 |
| 16:1420459:C:A | W62C | 0.925 |
| 16:1420459:C:G | W62C | 0.925 |
| 16:1420490:A:G | F52S | 0.922 |
| 16:1420461:A:G | W62R | 0.911 |
| 16:1420461:A:T | W62R | 0.911 |
| 16:1420371:A:G | W92R | 0.899 |
| 16:1420371:A:T | W92R | 0.899 |
| 16:1420357:C:A | R96S | 0.898 |
| 16:1420357:C:G | R96S | 0.898 |
| 16:1420368:A:G | C93R | 0.895 |
| 16:1420358:C:A | R96M | 0.880 |
| 16:1420481:C:A | S55I | 0.872 |
| 16:1420481:C:T | S55N | 0.872 |
| 16:1420358:C:G | R96T | 0.841 |
| 16:1420382:G:T | A88E | 0.822 |
| 16:1420340:T:A | D102V | 0.807 |
| 16:1420414:C:A | W77C | 0.803 |
| 16:1420414:C:G | W77C | 0.803 |
| 16:1420339:G:C | D102E | 0.796 |
dbSNP variants (sampled 300 via entrez): RS1000318633 (16:1422451 C>T), RS1001819866 (16:1422636 C>T), RS1002578574 (16:1422109 G>A), RS1003213206 (16:1420339 G>A,C,T), RS1003267625 (16:1420131 C>G), RS1004745771 (16:1422664 G>A,T), RS1005447294 (16:1420387 G>A), RS1007116505 (16:1420015 G>A,C), RS1007157155 (16:1421714 G>A), RS1008167844 (16:1420781 G>A,T), RS1009099218 (16:1421626 A>G), RS1010619480 (16:1419699 T>C), RS1010857728 (16:1420077 G>A), RS1010966089 (16:1421091 C>G,T), RS1011443500 (16:1420935 G>A,C,T)
Disease associations
OMIM: gene MIM:620578 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases mutagenesis, affects methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| abrine | increases expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | increases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Disulfiram | affects binding, decreases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E1SR | HAP1 C16orf91 (-) 1 | Cancer cell line | Male |
| CVCL_E1SS | HAP1 C16orf91 (-) 2 | Cancer cell line | Male |
| CVCL_E1ST | HAP1 C16orf91 (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.